Banco Bradesco SEC Filings

Banco Bradesco S.A. approved a large supplementary interest on shareholders’ equity distribution of R$3.9 billion, equal to R$0.351190748 per common share and R$0.386309823 per preferred share. Shareholders on record as of December 29, 2025 are entitled to receive it, and the shares trade ex-rights from December 30, 2025.

Payment will be made by July 31, 2026 at net amounts of R$0.298512136 per common share and R$0.328363349 per preferred share after 15% withholding tax, except for tax‑exempt legal entities, which receive the gross amount. Including monthly and interim distributions, total 2025 interest on shareholders’ equity reaches R$14.499 billion, or R$1.305594610 per common share and R$1.436154077 per preferred share.

The supplementary distribution alone is about 20.4 times the net monthly interest on shareholders’ equity and will be counted toward the company’s mandatory dividend for the fiscal year.

Banco Bradesco S.A. filed a Form 6-K detailing November 2025 share transactions involving its controlling group, management, family dependants and related entities. The controller and family dependants maintained their positions, holding 3,811,582,439 common shares and 121,067,106 non-voting shares, with no trades in the month.

Within the Board of Directors group and family dependants, non-voting shares decreased slightly as they sold 53,290 non-voting shares for R$ 1,018,897.68, while their common share holdings were unchanged. The Board of Executive Officers group and family dependants executed numerous small market sales of non-voting shares through Ágora C.T.V.M. S/A and Itaú Corretora de Valores S/A, with tabulated totals of 506,394 and 1,000 non-voting shares respectively.

Most subsidiaries and related companies listed, as well as the audit committee and technical and advisory agencies, reported no operations in Banco Bradesco securities or derivatives during November 2025, often showing zero or unchanged share balances. Overall, the filing describes routine insider and related-party trading disclosure with only modest changes in management-held non-voting shares.

Banco Bradesco S.A. outlined its key corporate dates for 2026. The bank plans to release its quarterly information for 2026 on April 29 (1st quarter), July 29 (2nd quarter), and October 28 (3rd quarter). An annual shareholder’s meeting is scheduled for March 10, 2026, with the management proposal and call notice both expected to be sent on February 6, 2026. The bank also scheduled a videoconference to present its third-quarter 2026 results on October 29, 2026. The document reiterates that any forward-looking statements are based on current management views and are subject to economic, industry, and operational risks that could cause actual results to differ.

Banco Bradesco S.A. (BBD) furnished a Form 6‑K detailing insider and related‑party share activity for October 2025.

The Board of Directors reported purchases of 206,701 non‑voting shares for R$ 3,768,510.47 and sales of 20,900 non‑voting shares for R$ 378,917.00, ending with 44,950,343 non‑voting shares. The Board of Executive Officers recorded purchases of 591,650 non‑voting shares for R$ 10,786,316.79 and sales of 3,438 non‑voting shares for R$ 62,178.42, closing with 11,982,712 non‑voting shares and 68,136 common shares. The Audit Committee reported a securities lending (rent) credit of 18,981 non‑voting shares, closing with 79,448 non‑voting shares.

Controller group balances were unchanged: 3,811,582,439 common shares and 121,067,106 non‑voting shares. Treasury held 7,500,000 common shares and 7,500,000 non‑voting shares with no transactions. Numerous controlled and related entities reported no operations in the month.

Banco Bradesco (BBD) announced that Atlântica Hospitais e Participações, an investment company in hospitals indirectly controlled by Bradesco and Bradseg Participações, signed an agreement with Rede D’Or to include Maternidade São Luiz Star in the “Atlântica D’Or” structure. The partnership maintains the existing ownership split of 50.01% for Rede D’Or and 49.99% for Atlântica, and Rede D’Or will be responsible for the hospital’s medical management.

The move extends the partnership first disclosed on May 8, 2024, with similar expansions announced in 2024 and 2025, and aligns with Atlântica’s strategy to invest across the healthcare value chain through partnerships with established hospital operators. Completion of the transaction is subject to customary suspensive conditions, including regulatory approvals.

Banco Bradesco S.A. reported stronger 3Q25 results, highlighting ongoing transformation and disciplined risk. Recurring net income reached R$6.2 billion (up 2.3% q/q; 18.8% y/y), and ROAE was 14.7%. Total revenue was R$35.0 billion (up 3.0% q/q; 13.1% y/y), driven by net interest income, fees and insurance.

NII totaled R$18.7 billion (up 3.7% q/q; 16.9% y/y); client NII advanced on higher spreads (8.8% to 9.0%) and loan growth. The expanded loan portfolio reached R$1.034 trillion (up 1.6% q/q; 9.6% y/y), with secured lines rising to 59.5%. The 90+ day delinquency ratio was 4.1%, stable, while the cost of credit edged to 3.3%.

Insurance operations delivered income of R$5.7 billion (up 13.0% y/y) and net income of R$2.5 billion, with ROAE of 22.4%. Operating expenses rose 3.7% q/q amid targeted investments, keeping efficiency near 50%. Capital remained sound: Tier 1 13.4% and CET1 11.4%. The bank allocated R$3.8 billion in interest on shareholders’ equity and met its goal to allocate up to R$350 billion to socio-environmental sectors by September 2025.

Banco Bradesco S.A. reported 3Q25 results with recurring net income of R$6.2 billion, up 2.3% quarter over quarter and 18.8% year over year. ROAE reached 14.7%. Total revenue was R$35.0 billion, led by net interest income of R$18.7 billion; client NII was R$18.6 billion as average spreads improved to 9.0%.

The expanded loan portfolio rose to R$1.034 trillion (↑1.6% q/q, ↑9.6% y/y), with greater participation of secured lines. The 90+ day delinquency ratio held at 4.1%, while the cost of credit ticked to 3.3%. Fee and commission income grew 2.8% q/q and 6.9% y/y. Insurance operations delivered income of R$5.7 billion and net income of R$2.5 billion, with a 22.4% ROAE.

Operating expenses increased 3.7% q/q and 9.6% y/y amid ongoing investments, keeping the efficiency ratio around 50%. Capital remained solid with a Tier 1 ratio of 13.4% and a common equity ratio of 11.4%. The company allocated R$3.8 billion in interest on shareholders’ equity and reached its R$350 billion sustainability allocation target by September 2025.

Banco Bradesco S.A. (BBD) reported stronger results for 9M25 under IFRS. Net income reached R$17,382,943 thousand, up from R$13,333,258 thousand a year earlier, with basic EPS of R$1.54 for common shares and R$1.70 for preferred shares. Shareholders’ equity totaled R$176,144,427 thousand, and book value per share was R$16.61.

Core banking volumes expanded: total deposits were R$667.1 billion (Sept25 vs. Sept24, +8.2%), the expanded loan portfolio was R$1,034.2 billion (+9.6%), and Tier I capital was 13.4%. Securities reached R$832.7 billion (+11.4%), with notable shifts among FVPL, FVOCI and amortized cost classifications.

The bank highlighted higher fee and commission income and stronger insurance and pension performance in 9M25. Expected loss on loans and advances was R$22,039,311 thousand for 9M25. Bradesco also approved interest on intermediate equity totaling R$3,000,000,000, or R$0.270146729 per common share and R$0.297161402 per preferred share, to be paid by April 30, 2026.

Banco Bradesco S.A. furnished a Form 6-K detailing equity transactions for September 2025 by management and related parties. The Board of Directors purchased 972,701 non-voting shares at R$17.63059, totaling R$17,149,289.16, ending with 44,764,542 non-voting shares.

The Board of Executive Officers recorded purchases of 2,345,092 non-voting shares for R$41,345,348.01 and sales of 52,631 non-voting shares for R$910,040.06, closing with 11,641,042 non-voting shares. The Controller's group reported no operations; balances remained at 3,811,582,439 common and 121,067,106 non-voting shares. Treasury shares were unchanged at 7,500,000 common and 7,500,000 non-voting. The Audit Committee and Technical/Advisory groups also reported no transactions.